Top

Published in:

01-11-2014 | Commentary

I want to fly home: a terminal cancer patient’s right to go home

Author: Cristian Zanartu

Published in: Supportive Care in Cancer | Issue 11/2014

Excerpt

As palliative care physicians, we sometimes find ourselves immersed in the dilemma of a patient with terminal cancer requesting to fly back home, often overseas. This particular situation is filled with an array of complex variables: establishing that the medical condition is stable enough for overseas travel, dealing with a significant cost (sometimes in patients with scarce economical resources), securing proper care on the receiving end, symptom management during flight, and dealing with the possibility of in-flight death, among others. …

Pan CX, Kales J, Sanchez-Reilly S (2004) I want to go home. Ann Intern Med 141(12):964–965PubMedCrossRef

(1986) Air Carrier Access Act, 49 USC §41705

Aerospace Medical Association Medical Guidelines Task Force (2003) Medical guidelines for airline travel. Aviat Space Environ Med 74(5 Suppl):A1

FAA approved portable oxygen concentrators. http://www.faa.gov/about/initiatives/cabin_safety/portable_oxygen/

Bettes THOMASN, McKenas DAVIDK (1999) Medical advice for commercial air travelers. Am Fam Physician 60(3):801–8PubMed

Pepperell JCT, Fraser C, McClue G (2011) P139 the use of venturi masks with oxygen concentrators. Thorax 66(Suppl 4):A123–A124CrossRef

Veldman A et al (2004) Long-distance transport of ventilated patients: advantages and limitations of air medical repatriation on commercial airlines. Air Med J 23(2):24–28PubMedCrossRef

DeHart RL (2003) Health issues of air travel. Annu Rev Public Health 24(1):133–151PubMedCrossRef

Peterson DC et al (2013) Outcomes of medical emergencies on commercial airline flights. N Engl J Med 368(22):2075–2083PubMedCrossRefPubMedCentral

10.

Silverman D, Gendreau M (2009) Medical issues associated with commercial flights. Lancet 373(9680):2067–2077PubMedCrossRef

11.

British Thoracic Society Standards of Care Committee (2002) Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 57(4):289CrossRef

12.

Coker RK, Shiner RJ, Partridge MR (2007) Is air travel safe for those with lung disease? Eur Respir J 30(6):1057–1063PubMedCrossRef

13.

Gavish I, Brenner B (2011) Air travel and the risk of thromboembolism. Intern Emerg Med 6(2):113–116PubMedCrossRef

14.

Cesarone MR et al (2002) Venous thrombosis from air travel: the LONFLIT3 study prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial. Angiology 53(1):1–6CrossRef

15.

Jagoda A, Pietrzak M (1997) Medical emergencies in commercial air travel. Emerg Med Clin North Am 15(1):251–260PubMedCrossRef

16.

Callahan D (1993) “The troubled dream of Life”. Simon & Schuster, New York

Title: I want to fly home: a terminal cancer patient’s right to go home
Author: Cristian Zanartu
Publication date: 01-11-2014
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 11/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-014-2391-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2014

Intensive nutritional counseling improves PG-SGA scores and nutritional symptoms during and after radiotherapy in Korean cancer patients

Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial

Quantitative tool to evaluate the somatic burden due to chemotherapy-induced adverse events: the somatic burden score

Health behaviors and needs of melanoma survivors

Research in cancer care disparities in countries with universal healthcare: mapping the field and its conceptual contours

Quality of life in head and neck cancer survivors at 1 year after treatment: the mediating role of unmet supportive care needs

Keynote webinar | Spotlight on antibody–drug conjugates in cancer